GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis

OBJECTIVE: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce glycaemia and weight and improve insulin resistance (IR) via different mechanisms. We aim to evaluate and compare the ability of GLP-1 RAs and SGLT-2 inhibitors to ameliorat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Hongle, Huang, Chunyi, Shen, Xuejun, Li, Jufang, Zhou, Shuyi, Li, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325993/
https://www.ncbi.nlm.nih.gov/pubmed/35909522
http://dx.doi.org/10.3389/fendo.2022.923606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325993/
https://www.ncbi.nlm.nih.gov/pubmed/35909522
http://dx.doi.org/10.3389/fendo.2022.923606

Ejemplares similares